To our delight, no statistically significant differences were observed in adjacent normal tissue in response to CRT, except the expression level of PARP12 was found to be slightly lower than before CRT (p < 0.05) signaling a significantly specific tumor cell PARP-related response to the therapy course. This evidence concerns the gene PARP12 and neoplasm.